- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07855185
Trapezius Oxygenation and Cervical Function in Chronic Neck Pain
Association Between Trapezius Muscle Oxygenation and Cervical Function in Individuals With Chronic Neck Pain
The aim of this study is to investigate the relationship between trapezius muscle oxygenation and cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.
Study Overview
Status
Conditions
Detailed Description
Chronic neck pain is a common musculoskeletal condition associated with impaired cervical mobility, reduced muscle performance, and increased disability. Alterations in local muscle oxygenation and microcirculation, particularly in the trapezius muscle, may contribute to persistent symptoms and functional limitations. Near-infrared spectroscopy provides a non-invasive method for assessing muscle oxygenation and hemodynamic responses. This study aims to investigate the relationship between trapezius muscle oxygenation, cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Başak Kavalcı Kol, PhD
- Phone Number: +903862802317
- Email: basak.kavalci@ahievran.edu.tr
Study Locations
-
-
-
Kırşehir, Turkey (Türkiye), 40100
- Kırşehir Ahi Evran University.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Adults aged 18-65 years with chronic neck pain lasting for at least 12 weeks who meet the study eligibility criteria.
Description
Inclusion Criteria:
- Aged 18-65 years.
- Chronic neck pain lasting for at least 3 months.
- Neck pain intensity of ≥3 on the Visual Analog Scale during activity.
- Willingness to participate in the study.
Exclusion Criteria:
- Motor deficit in the upper extremities.
- History of cervical or upper-extremity surgery.
- Rheumatologic or neurologic disease.
- Any musculoskeletal condition affecting upper-extremity function.
- Cervical injection or other invasive procedure within the previous 6 months.
- Cognitive impairment preventing understanding or performance of study assessments.
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
|---|
|
Chronic Neck Pain Group
Adults aged 18-65 years with chronic neck pain lasting at least 12 weeks will be included in the study. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trapezius Muscle Oxygen Saturation
Time Frame: First Day
|
Trapezius muscle oxygen saturation will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise. |
First Day
|
|
Trapezius Total Hemoglobin
Time Frame: First day
|
Trapezius total hemoglobin will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise. |
First day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trapezius Muscle Strength
Time Frame: Second Day
|
Upper and middle trapezius muscle strength will be measured using a handheld dynamometer. |
Second Day
|
|
Cervical Range of Motion
Time Frame: Second day
|
Active cervical flexion, extension, lateral flexion, and rotation will be measured using a goniometer. |
Second day
|
|
Neck Disability
Time Frame: Second day
|
Disability will be assessed using the Neck Disability Index (NDI; 0-50 points), with higher scores indicating greater disability. |
Second day
|
|
Upper-Extremity Exercise Capacity
Time Frame: First Day
|
Maximum upper-extremity exercise capacity will be assessed using an arm ergometer test, with peak workload recorded in watts. |
First Day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AhiEvranU531
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.